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1. Introduction 
Calcitonin, a hypocalcemic hypophosphatemic hor- 
mone [1,2], acts through specific receptors in kidney and 
bone [3]. Calcitonin receptors, characterized by specific 
binding of the hormone or activation of adenylate 
cyclase, are detected in several normal and malignant 
tissues and cell lines. The presence of putative calcitonin 
receptors on C cells has been suggested as exogenous 
calcitonin inhibits its own secretion by normal [4] or 
malignant C cells [5]. The sequence of the calcitonin 
receptor is now established in pig [6], human [7] and rat 
[8]. We have searched, using the polymerase chain reac- 
tion [9] and specific primers, for the presence of this 
receptor in the TT cells [lo]. This cell line is derived from 
human medullary thyroid carcinoma (MTC). We report 
here that an isoform of the calcitonin receptor is ex- 
pressed in TT cells. We also detected the presence of this 
receptor in tissues removed at surgery from two MTC 
cases. Thus an autocrine process of regulation could be 
implicated in the secretion of calcitonin by the malignant 
cells in vitro or in vivo. 
Abstract 
We amplified, using the polymerase chain reaction and calcitonin receptor (CTR) specific primers, RNA extracted from medullary thyroid 
carcinoma (MTC) and the derived TT cell line. Both secrete large amounts of calcitonin. Electrophoresis of amplification products revealed, in both 
cases, an ethidium bromide-stained band that hybridized to a CTR probe. Sequencing the band amplified from TT cells revealed an open reading 
frame identical to the sequence of H-CTR but lacking 16 amino acids in the first intracellular loop. This demonstrates the existence of an mRNA 
coding for a subtype of H-CTR which is expressed in TT cells and MTC. 
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2. Materials and methods 
2.1. Cell culture 
TT cells were cultured in RPMI, 10 mM HEPES, 6 mM glutamine, 
supplemented with 10% fetal calf serum. The medium was changed 
every two days and the cells were harvested at confluence. 
2.2. RNA extraction 
Total RNA was extracted from TT cells or from MTC tissues by a 
guanidine thiocyanate chloride method [1 11. All extracts were immedi- 
ately frozen at -80°C or stored at -20°C in 75% ethanol until used. 
2.3. RT-polymerase chain reaction 
cDNA was synthesized from 5 pg of total RNA. The reaction mixture 
had a final volume of 20 ~1, and contained 50 mM KCl, 20 mM 
Tris-HCl (pH 8.4) 2.5 mM MgCl*, nuclease-free BSA (1 mg/ml), 20 U 
of RNAsin, 200 U of reverse transcriptase superscript (BRL), 1 mM 
of each dNTP and 50 pmol of a 3’ oligo-dT primer. Annealing was 
performed during 10 min at 23°C and primer extension during one hour 
at 37°C. The reaction mixture was then completed to 95 ~1 with Taq 
polymerase buffer containing 2 units of Taq polymerase (Eurobio). 
After heating to 90°C (hot-start), 50 pmol of each specific primer in 5 yl 
were added. Amplification was performed during 30 cycles: 1 min at 
95°C (denaturation), 1 min at 55°C (annealing) and 1 min at 72°C 
(extension). 
Oligonucleotide primers spanning the entire coding sequence of the 
human calcitonin receptor were used (Fig. 1). RNA samples pretreated 
with RNAase A were also amplified as controls. 
2.4. Analysis of PCR products 
*Corresponding author. Fax: (33) 49 95 84 52. 
Abbreviations: CTR, calcitonin receptor; H-CTR, human calcitonin 
receptor; P-CTR, pig calcitonin receptor; R-CTR, rat calcitonin recep- 
tor; MTC, medullary thyroid carcinoma; SDS, sodium dodecyl sulfate; 
SSC, sodium saline citrate; RT-PCR, reverse transcriptase polymerase 
chain reaction. 
Amplified products were analyzed by electrophoresis on 1.2% aga- 
rose gels, visualized by ethidium bromide, transferred to membranes 
(GeneScreen NEN). The amplified cDNA was hybridized with a CTR 
specific cDNA probe radiolabelled with 32P using a random priming 
method (specific activities 2 10’ cpm/,ug DNA were obtained). After 
prehybridization for 4 h at 42°C in 50% deionized formamide, 1% SDS, 
2 x SSC, 10% dextran sulfate, the membranes were hybridized at 42°C 
in the same buffer containing the specific CTR cDNA probe and were 
washed at 55”C, in 2 x SSC for 10 min, twice 2 x SSC containing 0.1% 
SDS for 20 min, and twice 1 x SSC containing O,l% SDS for 20 min. 
Autoradiography was performed at -80°C with intensifying screens 
overnight. 
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2.5. Cloning and DNA sequencing 
After precipitation of PCR products, cDNA fragments were cloned 
into plasmid pCRI1 using the TA cloning kit (Invitrogen, Inc). Positive 
clones were selected with a radiolabelled CTR specific probe Both 
strands of cDNA fragments were sequenced with the ds cDNA cycle 
sequencing system kit (Gibco BRL) using Ml3 reverse and Ml340 
primers labeled with [r-“PjATP and Taq DNA polymerase. Amplifica- 
tion was carried out for 20 cycles (30 s at 9SC, 30 s at WC, 1 min at 
70°C) followed by 10 cycles (30 s at 95°C 1 min at 7O’C). 
3. Results 
Fig. 1 shows the three sets of primers (upper panel) 
spanning the coding region of the calcitonin receptor 
(lower panel) we used. When RNA extracted from TT 
cells was amplified using these primers, agarose gel elec- 
trophoresis of the amplified products revealed the pres- 
ence of a single ethidium-stained band with each set of 
primers used. These bands were not detected if the sam- 
ples were pretreated with RNase A. However the band, 
amplified with primers (II) spanning transmembrane re- 
gions I and II was shorter (529 bp) than the awaited size 
(577 bp) by appro~mately 50 bases (Fig. 2a). All the 
bands obtained with the other two sets of primers had 
the expected length (results not shown). After transfer of 
the amplified products to a GeneScreen membrane and 
hybridization with a specific calcitonin receptor cDNA 
probe, a strong hybridization signal was consistently ob- 
served (Fig. 2b). Sequencing of the products amplified 
with the three sets of primers allowed us to deduce the 
complete coding sequence of the molecular species pres- 
ent in the TT cells. This sequence was identical to the one 
reported by Gorn et al. [7], with the exception of 16 
amino acids which were missing between transmembrane 
domains I and II (Fig. 3) and the substitution of a serine 
for lysine at position 175 of the amino acid sequence. A 
strong signal was also observed when RNA extracted 
from two cases of MTC was reverse-transcribed, ampli- 
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Fig. 1. Upper panel: sequence of primers used to amplify the H-CTR 
coding sequence. Lower panel: sequencing strategy. Arrows represent 
the position of the set of primers used and the direction of amplification 
and sequencing. 
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Fig. 2. (a) Agarose gel electrophoresis of amplification products (using 
primer set II) of RNA extracted from ‘IT cells stained with ethidium 
bromide. Lanes (1,2) Amplification products from two different pools 
of TT cells harvested at confluence. (b) Autoradiography of the South- 
ern blot of the above amplification products hyb~~z~ to a ‘2P-labelled 
CTR probe. 
fied, transferred and hybridized to the calcitonin recep- 
tor probe (Fig. 4). No difference in size between the 
amplification products of MTC and ‘IT cells was ob- 
served with primers II and III (results not shown). 
4. Discussion 
The calcitonin receptor [6] is a seven transmembrane 
receptor coupled to adenylate cyclase pathway and be- 
longing to a new family of transmembrane receptors 
which includes the parathyroid [12] and secretin 1131 re- 
ceptors. In the species so far studied a single form is 
reported in human and pig while two isoforms exist in 
rat. The human receptor differs from the other known 
receptors (porcine, murine) by the existence of an insert 
of 16 amino acids in the intracellular loop separating the 
first and second transmembrane domains. 
Our results clearly demonstrate that a mRNA express- 
ing a calcitonin like receptor molecule is present in the 
TT cells. This messenger is functional as we used an 
oligo-dT primer and reverse transcriptase to obtain the 
first strand before amplification. The sequence of this 
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Fig. 3. Deduced amino acid sequence of the first two transmembrane 
domains of the isoform present in TI cells compared to the correspond- 
ing regions of the human, rat and porcine receptors. Amino acid iden- 
tities in the four sequences are shown by a vertical line (I). 
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Fig. 4. Autoradiography of a Southern blot of amplification products 
(using primer set I) of RNA extracted from TT cells (lane 1) and MTC 
(lane 2) hybridized to a ‘*P-labelled CTR probe. 
isoform is identical to that reported for human calcitonin 
with the exception of a gap of 48 nucleotides imilar to 
the gap found in the messengers coding for the porcine 
receptor and in the two isoforms of the murine receptor. 
Thus an isoform of the human receptor (H-CTRb) exists 
which has a shorter intracellular loop (13 amino acids) 
than the form (H-CTRa) reported by Gorn et al. (29 
amino acids). We also detected the presence of this mes- 
senger in the tissues of patients suffering from medullary 
carcinoma of the thyroid. In the two cases, in which we 
have detected the receptor mRNA, the species present 
corresponded in size to that detected in TT cells and thus 
could express a receptor molecule with a truncated intra- 
cellular loop. 
The expression of the calcitonin receptor gene in C 
cells could explain the results reported previously on the 
inhibition of calcitonin secretion by the addition of ex- 
ogenous hormone in both normal [4] and tumoral C cells 
[5]. This inhibition could be due to the hormone acting 
through the putative receptor we report here. In this case 
an autocrine or paracrine system regulating calcitonin 
secretion could exist in tumoral C cells. 
Further studies are necessary to establish if this sub- 
type of the human receptor is restricted to tumoral C 
cells or is expressed in normal tissues and if it is func- 
tional. The presence of this receptor in medullary carci- 
noma tissue raises the question of the potential role of 
this receptor during oncogenesis and its role as a tumoral 
marker. 
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